Ionis Pharmaceuticals, Inc.IONSNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank71
3Y CAGR+4.2%
5Y CAGR+6.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+4.2%/yr
vs +66.9%/yr prior
5Y CAGR
+6.0%/yr
Consistent
Acceleration
-62.6pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.99M | +42.6% |
| 2024 | $11.21M | +22.8% |
| 2023 | $9.13M | -35.3% |
| 2022 | $14.12M | +30.2% |
| 2021 | $10.84M | -9.2% |
| 2020 | $11.95M | +172.5% |
| 2019 | $4.38M | +140.9% |
| 2018 | $1.82M | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |